SEC Form 4 · accession 0000899243-16-028188
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel W Muehl
Officer — See Remarks
Period of report
Aug 25, 2016
Accepted (ET)
Aug 29, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.73 | Aug 25, 2016 | A | 37,500 | A | — | Aug 25, 2026 | Common Stock | 37,500 | 37,500 | D |
| Restricted Stock UnitsF2,F3 | — | Aug 25, 2016 | A | 8,750 | A | — | — | Common Stock | 8,750 | 8,750 | D |
| Stock Option (right to buy)F4,F5 | $84.83 | holding | — | — | — | — | Jul 6, 2025 | Common Stock | 35,000 | 35,000 | D |
| Stock Option (right to buy)F4,F5 | $19.37 | holding | — | — | — | — | Mar 1, 2026 | Common Stock | 7,500 | 7,500 | D |
| Restricted Stock UnitsF2,F6,F7 | — | holding | — | — | — | — | — | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1The option shall vest as to 25% of the shares on August 25, 2017, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date.
- F2Each restricted stock unit represents the right to receive one share of Common Stock.
- F3The restricted stock units shall vest as to 25% of the units on August 25, 2017, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date.
- F4The option vested as to 25% of the shares on July 6, 2016, and the remainder vest in substantially equal installments over the 36 months immediately following such date.
- F5The vesting schedule for this option was incorrectly reported on a previously filed Form 3. This Form 4 reflects the correct vesting schedule.
- F6The restricted stock units shall vest as to 50% of the units on March 1, 2017, and the remainder shall vest on March 1, 2018.
- F7An expiration date was incorrectly reported for these restricted stock units on a previously filed Form 3. This Form 4 reflects that the restricted stock units do not have such an expiration date.
Remarks
Vice President of Finance, Principal Financial Officer and Principal Accounting Officer